Oncotelic Therapeutics OTLC
OTC OTLC
$0.02 +0.00 (+11.80%)
As of: Oct 23, 2026 · 12:56 PM EDT

Oncotelic Therapeutics (OTLC) Revenue (2012 - 2026)

Updated

Oncotelic Therapeutics (OTLC) posted Revenue of $250,000 for Q2 2026.

Analysis

Oncotelic Therapeutics (OTLC) Revenue (2012 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Revenue at Oncotelic Therapeutics was $320,000; for FY2023, it was $70,000.

  • Annual Revenue shows a three-year compound annual growth rate of -65.7% (FY2020 to FY2023).
  • In prior years, Oncotelic Therapeutics' Revenue was $500,000 in FY2021 (-71.3%) and $1.74 million in FY2020.
  • The Q2 2026 figure stands as the highest quarterly Revenue since Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 25.40 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 16.99 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 15.38 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 7.80 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 15.03 Bn
10 Oncotelic Therapeutics 8.05 Mn 7.20 Mn - 250,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 250,000.00
Sep 30, 2023 70,000.00
Mar 31, 2021 500,000.00
Jun 30, 2020 1.40 Mn
Mar 31, 2020 340,855.00
Sep 30, 2013 95,000.00
Dec 31, 2012 42,000.00
Mar 31, 2012 114,000.00
API Access

Oncotelic Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=OTLC&period=max&api_key=YOUR_API_KEY